The Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Mild Hypertension
Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of Irbesartan 150/12.5 mg and
300/25 mg in patients with hypertension not controlled by monotherapy.